| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.60B | 92.70B | 77.82B | 80.93B | 78.02B | 72.06B |
| Gross Profit | 86.59B | 85.30B | 74.86B | 76.71B | 73.15B | 67.27B |
| EBITDA | 26.97B | 26.50B | 22.92B | 7.45B | 26.75B | 23.38B |
| Net Income | 20.21B | 17.62B | 15.02B | 3.92B | 15.46B | 13.59B |
Balance Sheet | ||||||
| Total Assets | 6.00T | 5.93T | 5.83T | 5.48T | 5.88T | 5.66T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 807.02B | 983.68B | 1.00T | 1.38T | 1.22T |
| Total Debt | 932.08B | 882.76B | 856.00B | 530.31B | 1.99T | 894.03B |
| Total Liabilities | 5.76T | 5.69T | 5.59T | 5.26T | 5.64T | 5.42T |
| Stockholders Equity | 241.42B | 235.19B | 237.15B | 222.02B | 241.14B | 244.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 45.99B | 0.00 | -585.29B | 72.24B | 712.94B |
| Operating Cash Flow | 0.00 | 48.82B | 0.00 | -582.29B | 75.53B | 715.23B |
| Investing Cash Flow | 0.00 | 16.95B | -130.55B | 214.64B | 87.36B | -2.06B |
| Financing Cash Flow | 0.00 | 45.50B | 89.70B | -5.61B | -4.57B | -4.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥265.81B | 14.45 | ― | 2.13% | 7.77% | 5.80% | |
71 Outperform | ¥267.98B | 8.21 | 7.61% | 3.81% | 17.68% | 20.15% | |
68 Neutral | ¥283.46B | 9.68 | ― | 2.27% | 2.68% | 74.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥249.62B | 8.20 | ― | 3.46% | 11.92% | 16.40% | |
65 Neutral | ¥250.12B | 10.90 | ― | 2.53% | 7.67% | 11.03% | |
59 Neutral | ¥263.94B | 10.68 | ― | 2.55% | -0.36% | 41.38% |